Osaic Holdings’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
Bought
Maintained
Sold
Other funds holding STAB
Osaic Holdings's STAB Position: Q1 2023 in Review
Osaic Holdings sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 30,300 shares — an estimated $2K sold.
Osaic Holdings first reported a position in STAB in Q1 2020 and held it in 11 quarters. The position peaked at $2K in Q4 2022. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.
- Osaic Holdings reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Osaic Holdings sold 30,300 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $2K.
- Osaic Holdings first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2020 and held it in 11 quarters.
- Osaic Holdings's Statera Biopharma, Inc. Common Stock position peaked at $2K in Q4 2022.
- 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.
Based on Osaic Holdings's 13F filing for Q1 2023, filed 12 May 2023.